Disease | Cells/exosomes | Engineering technology | Results | References |
---|---|---|---|---|
RA | MSCs | Genetically modified MSCs to overexpress HsTNFR2 | Prevented arthritis symptoms | [121] |
 | MSCs | Genetically modified MSCs to overexpress HGF | Alleviated joint inflammation in CIA mice | [122] |
 | MSCs | Gene transfer of etanercept-loaded micro circular plasmids to MSCs by electroporation | Improved arthritis symptoms in CIA mice | [123] |
 | hMSCs | Epigenetic modification of hMSCs to enhance cellular function | Enhanced immune suppression | [124] |
 | MSCs | MTX- and TGFβ1-loaded hydrogels combine with MSCs | Anti-inflammatory | [125] |
 |  |  | Promoted cartilage differentiation of MSCs |  |
 | MSC-Exos | Surface modification of MSC-Exos by metabolic glycoengineering | Promoted polarization of macrophages and reduced the activity of pro-inflammatory cells at the inflammatory site in CIA mice | [158] |
 | Exos | Surface modification of MSC-Exos to establish targeted drug delivery system | Alleviated joint inflammation in CIA mice | [159] |
SLE | MSCs | Lentiviral transfection of MSCs to overexpress IL-37 | Inhibition of inflammatory factors | [132] |
 |  |  | Relieved symptoms in lupus model mice |  |
OA | MSCs | 3D culture of MSCs | Reduced inflammation, fibrosis, and cartilage degradation in vivo and in vitro | [138] |
 | MSCs | Epigenetically reprogrammed MSCs | Increased in vitro proliferation ability and improve articular chondrocyte differentiation | [139] |
 | BMSC-Exos | Hydrophilic Hydrogel combined with Exos | Promoted cartilage regeneration and remodeling | [160] |
 | MSC-EVs | MSC-EVs modified by PPD to changes its surface charge | Increased absorption, penetration and retention in cartilage | [161] |
IBD | MSCs | Genetically modified MSCs to overexpress ICAM-1 | Enhance immune regulation and reduce colon tissue damage | [147] |
 | MSCs | ICAM-1-coated MSCs | Promotes adhesion to endothelial cells | [151] |
 | MSCs | VCAM-1-coated MSCs | Prolonged survival in IBD mice | [152] |
 | MSC-EVs | Lentiviral transfection of MSC-EVs to overexpress PD-1 | Targeted lesions for immune regulation | [163] |
 | EVs | Designed a DNA aptamer to enhance EVs mRNA delivery | Efficiently induced browning of white adipocytes | [164] |
 |  |  | Promoted anti-inflammatory in IBD mice |  |